secwatch.observer — SEC 8-K summary
======================================

Issuer:     RHYTHM PHARMACEUTICALS, INC. (RYTM)
CIK:        0001649904
Form:       8-K
Filed at:   2025-12-19T23:59:59+00:00
Accession:  0001104659-25-123108
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Dr. Camille Bedrosian resigns from Rhythm Pharmaceuticals board
---------------------------------------------------------------

- Camille L. Bedrosian, M.D. resigned from the Board effective December 16, 2025.
- She served on the Compensation & Management Development and Governance and Nominating Committees.
- Resignation not due to any disagreement with the Company or its operations, policies, or practices.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1649904/000110465925123108/0001104659-25-123108-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1649904/000110465925123108/rytm-20251216x8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-123108

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer